Efficacy of Hookworm Vaccine Assessed by Controlled Challenge Infection

This is a 14-month, randomized, Phase 2 clinical study comparing the impact of Na-GST-1 vaccination on controlled human hookworm infection in healthy volunteers. Participants will receive 3 injections of the investigational hookworm vaccine (or placebo), followed by infection with 50 human hookworm larvae.

Sponsor(s)
NIH
Principal Investigator(s)
David Diemert, MD/Medicine
Contact Phone Number
Request Information
Address

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

4 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.